Post-mortem toxicology analysis in a young sudden cardiac death cohort.


Journal

Forensic science international. Genetics
ISSN: 1878-0326
Titre abrégé: Forensic Sci Int Genet
Pays: Netherlands
ID NLM: 101317016

Informations de publication

Date de publication:
07 2022
Historique:
received: 21 12 2021
revised: 12 04 2022
accepted: 12 05 2022
pubmed: 1 6 2022
medline: 22 6 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

Risk of sudden cardiac death (SCD) increases with age, and several studies have examined the impact of different drugs on cardiovascular function. However, few studies have integrated epidemiological drug consumption data and genetic background in the context of cardiac death. We performed a retrospective population-based study in forensic sudden death cases from a 9-year period in Catalonia. The young cohort included 924 cases 18-50 years old, 566 of which had a cardiac cause of death. Complete autopsy, toxicological, and histopathological studies were performed. Molecular autopsy using next-generation sequencing was performed in nearly 400 cardiac cases. Cases related with fatal acute intoxication were excluded. Drug consumption prevalence was similar between forensic cases of cardiac and non-cardiac origin (62.5% versus 69.5%), with the exception of alcohol, which was more prevalent in the cardiac group than in the non-cardiac group (23.3% versus 17.1%). Individuals in the toxicology-positive group were carriers of more rare genetic variants and were significantly younger than the toxicology-negative group. Psychopharmacological drugs were identified in 22.3% of cardiac cases, and molecular autopsy identified an association between antiepileptic drugs or caffeine and pathogenic or likely pathogenic variants in arrhythmogenic genes. Specific substances could therefore play an essential role as triggers of SCD in genetically predisposed young people.

Identifiants

pubmed: 35640313
pii: S1872-4973(22)00064-3
doi: 10.1016/j.fsigen.2022.102723
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102723

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Mònica Coll (M)

Cardiovascular Genetics Centre, University of Girona-IDIBGI, Salt 17190, Spain. Electronic address: mcoll@gencardio.com.

Anna Fernàndez-Falgueras (A)

Cardiology Department, Hospital Universitari Doctor Josep Trueta, Girona 17003, Spain.

Coloma Tiron (C)

Cardiology Department, Hospital Universitari Doctor Josep Trueta, Girona 17003, Spain.

Anna Iglesias (A)

Cardiovascular Genetics Centre, University of Girona-IDIBGI, Salt 17190, Spain.

Maria Buxó (M)

Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt 17190, Spain.

Adrià Simón (A)

Cardiovascular Genetics Centre, University of Girona-IDIBGI, Salt 17190, Spain.

Laia Nogué-Navarro (L)

Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Can Baumann, Vic 08500, Spain.

Sergio Moral (S)

Cardiology Department, Hospital Universitari Doctor Josep Trueta, Girona 17003, Spain; Institut d'Investigació Biomèdica de Girona (IDIBGI), Salt 17190, Spain.

Alexandra Pérez-Serra (A)

Cardiovascular Genetics Centre, University of Girona-IDIBGI, Salt 17190, Spain.

Marta Puigmulé (M)

Centro de Investigación Biomédica en Red, Enfermedades Cardiovasculares (CIBER-CV), Madrid 28029, Spain.

Bernat Del Olmo (B)

Cardiovascular Genetics Centre, University of Girona-IDIBGI, Salt 17190, Spain.

Oscar Campuzano (O)

Cardiovascular Genetics Centre, University of Girona-IDIBGI, Salt 17190, Spain; Centro de Investigación Biomédica en Red, Enfermedades Cardiovasculares (CIBER-CV), Madrid 28029, Spain; Medical Science Department, School of Medicine, University of Girona, Girona 17003, Spain.

Josep Castellà (J)

Forensic Pathology Service, Institut Medicina Legal Ciències Mèdiques Catalunya, Barcelona, Spain.

Ferran Picó (F)

Cardiovascular Genetics Centre, University of Girona-IDIBGI, Salt 17190, Spain.

Laura Lopez (L)

Cardiovascular Genetics Centre, University of Girona-IDIBGI, Salt 17190, Spain.

Nuria Neto (N)

Cardiovascular Genetics Centre, University of Girona-IDIBGI, Salt 17190, Spain.

Mònica Corona (M)

Cardiovascular Genetics Centre, University of Girona-IDIBGI, Salt 17190, Spain.

Mireia Alcalde (M)

Cardiovascular Genetics Centre, University of Girona-IDIBGI, Salt 17190, Spain.

Ramon Brugada (R)

Cardiovascular Genetics Centre, University of Girona-IDIBGI, Salt 17190, Spain; Cardiology Department, Hospital Universitari Doctor Josep Trueta, Girona 17003, Spain; Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), Can Baumann, Vic 08500, Spain; Centro de Investigación Biomédica en Red, Enfermedades Cardiovasculares (CIBER-CV), Madrid 28029, Spain; Medical Science Department, School of Medicine, University of Girona, Girona 17003, Spain.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH